LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Inhaled Therapies Aerami Therapeutics specializes in developing inhaled medicines for severe respiratory and cardiopulmonary conditions, presenting opportunities to partner with healthcare providers and payers seeking advanced, patient-friendly treatment options.

Expanding Clinical Data The recent presentation of Phase 1 clinical trial data for AER-901 indicates active product development and potential for expanding into markets focused on pulmonary hypertension, creating avenues for collaborative clinical and commercialization efforts.

Strong Capital Support With $5.4 million in funding and a revenue range of $1M to $10M, Aerami has the financial backing and growth trajectory that appeal to investors and partners interested in innovative biotech solutions targeting cardiopulmonary diseases.

Leadership & Strategic Growth Leadership promotions and new hires, including a recent CEO appointment, signal a strategic focus on accelerating product development and market entry, inviting engagement from stakeholders focused on scaling novel respiratory therapies.

Technology & Infrastructure Utilizing cloud-based platforms like AWS and PWA development tools, Aerami demonstrates a modern, tech-driven approach to research and data management, opening opportunities for collaborations in digital health and medical technology integration.

Dance Biopharm Inc. Tech Stack

Dance Biopharm Inc. uses 8 technology products and services including Amazon Web Services, WP Engine, HSTS, and more. Explore Dance Biopharm Inc.'s tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • WP Engine
    Platform As A Service
  • HSTS
    Security
  • hCaptcha
    Security
  • X-XSS-Protection
    Security
  • X-Content-Type-Options
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • Apache HTTP Server
    Web Servers

Media & News

Dance Biopharm Inc.'s Email Address Formats

Dance Biopharm Inc. uses at least 2 format(s):
Dance Biopharm Inc. Email FormatsExamplePercentage
FLast@dancebiopharm.comJDoe@dancebiopharm.com
95%
First.Last@dancebiopharm.comJohn.Doe@dancebiopharm.com
5%
FLast@aerami.comJDoe@aerami.com
57%
Last@aerami.comDoe@aerami.com
43%

Frequently Asked Questions

Where is Dance Biopharm Inc.'s headquarters located?

Minus sign iconPlus sign iconDance Biopharm Inc.'s main headquarters is located at 2520 Meridian Parkway 400 Durham, North Carolina 27713 United States. The company has employees across 3 continents, including North AmericaEuropeOceania.

What is Dance Biopharm Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Dance Biopharm Inc.'s main corporate office by phone at
+1-415-769-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Dance Biopharm Inc.'s official website and social media links?

Minus sign iconPlus sign iconDance Biopharm Inc.'s official website is aerami.com and has social profiles on LinkedIn.

What is Dance Biopharm Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconDance Biopharm Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Dance Biopharm Inc. have currently?

Minus sign iconPlus sign iconAs of March 2026, Dance Biopharm Inc. has approximately 16 employees across 3 continents, including North AmericaEuropeOceania. Key team members include Chief Executive Officer At Aerami Therapeutics: L. Y.Chief Executive Officer And Gbl: T. C.Chief Medical Officer: G. B.. Explore Dance Biopharm Inc.'s employee directory with LeadIQ.

What industry does Dance Biopharm Inc. belong to?

Minus sign iconPlus sign iconDance Biopharm Inc. operates in the Biotechnology Research industry.

What technology does Dance Biopharm Inc. use?

Minus sign iconPlus sign iconDance Biopharm Inc.'s tech stack includes Amazon Web ServicesWP EngineHSTShCaptchaX-XSS-ProtectionX-Content-Type-OptionsGoogle AnalyticsApache HTTP Server.

What is Dance Biopharm Inc.'s email format?

Minus sign iconPlus sign iconDance Biopharm Inc.'s email format typically follows the pattern of FLast@dancebiopharm.com. Find more Dance Biopharm Inc. email formats with LeadIQ.

How much funding has Dance Biopharm Inc. raised to date?

Minus sign iconPlus sign icon As of March 2026, Dance Biopharm Inc. has raised $5.4M in funding. The last funding round occurred on Sep 20, 2022 for $5.4M.

When was Dance Biopharm Inc. founded?

Minus sign iconPlus sign iconDance Biopharm Inc. was founded in 2010.

Dance Biopharm Inc.

Biotechnology ResearchNorth Carolina, United States11-50 Employees

Aerami Therapeutics is breathing life into the treatment of serious and rare cardiopulmonary conditions with a mission-driven objective: develop products that help patients live longer and help them live better. We do this by combining precision medicines and advanced administration platforms that support ease-of-use and quality-of-life. 

Our lead program, AER-901 (inhaled imatinib) in pulmonary hypertension, has been intentionally designed to potentially reverse the damage caused by disease progression while overcoming many of the limitations of oral, parenteral, and other inhaled delivery technologies. 

To learn more, visit: https://aerami.com/

#Aerami #Cardiopulmonary #PulmonaryHypertension #PulmonaryArterialHypertension #PH #PAH #ILD #HeartDisease #LungDisease #InhaledTherapeutics #AER901 #AER601

Section iconCompany Overview

Headquarters
2520 Meridian Parkway 400 Durham, North Carolina 27713 United States
Phone number
+1-415-769-****
Website
aerami.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $5.4M

    Dance Biopharm Inc. has raised a total of $5.4M of funding over 9 rounds. Their latest funding round was raised on Sep 20, 2022 in the amount of $5.4M.

  • $1M$10M

    Dance Biopharm Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $5.4M

    Dance Biopharm Inc. has raised a total of $5.4M of funding over 9 rounds. Their latest funding round was raised on Sep 20, 2022 in the amount of $5.4M.

  • $1M$10M

    Dance Biopharm Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    L. Y.
    Chief Executive Officer At Aerami Therapeutics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. C.
    Chief Executive Officer And Gbl
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. B.
    Chief Medical Officer
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.